Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial.
Mehilli J, Ndrepepa G, Kastrati A, Neumann FJ, ten Berg J, Bruskina O, Dotzer F, Seyfarth M, Pache J, Kufner S, Dirschinger J, Berger PB, Schömig A. Mehilli J, et al. Among authors: seyfarth m. Am Heart J. 2007 Jul;154(1):158.e1-7. doi: 10.1016/j.ahj.2007.03.050. Am Heart J. 2007. PMID: 17584569 Clinical Trial.
Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial.
Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J, Martinoff S, Neumann FJ, Nekolla S, Blasini R, Seyfarth M, Schwaiger M, Schömig A; Stent versus Thrombolysis for Occluded Coronary Arteries in Patients With Acute Myocardial Infarction (STOPAMI-2) Study. Kastrati A, et al. Among authors: seyfarth m. Lancet. 2002 Mar 16;359(9310):920-5. doi: 10.1016/S0140-6736(02)08022-4. Lancet. 2002. PMID: 11918909 Clinical Trial.
Essential myosin light chain as a target for caspase-3 in failing myocardium.
Moretti A, Weig HJ, Ott T, Seyfarth M, Holthoff HP, Grewe D, Gillitzer A, Bott-Flügel L, Schömig A, Ungerer M, Laugwitz KL. Moretti A, et al. Among authors: seyfarth m. Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11860-5. doi: 10.1073/pnas.182373099. Epub 2002 Aug 19. Proc Natl Acad Sci U S A. 2002. PMID: 12186978 Free PMC article.
Statin treatment following coronary artery stenting and one-year survival.
Schömig A, Mehilli J, Holle H, Hösl K, Kastrati D, Pache J, Seyfarth M, Neumann FJ, Dirschinger J, Kastrati A. Schömig A, et al. Among authors: seyfarth m. J Am Coll Cardiol. 2002 Sep 4;40(5):854-61. doi: 10.1016/s0735-1097(02)02053-3. J Am Coll Cardiol. 2002. PMID: 12225707 Free article. Clinical Trial.
Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR-DIRECT trial).
Mehilli J, Kastrati A, Dirschinger J, Etzel L, Bollwein H, Pache J, Schühlen H, Von Beckerath N, Seyfarth M, Schmitt C, Schömig A. Mehilli J, et al. Among authors: seyfarth m. Catheter Cardiovasc Interv. 2004 Feb;61(2):190-5. doi: 10.1002/ccd.10706. Catheter Cardiovasc Interv. 2004. PMID: 14755810 Clinical Trial.
Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.
Kastrati A, Mehilli J, Schlotterbeck K, Dotzer F, Dirschinger J, Schmitt C, Nekolla SG, Seyfarth M, Martinoff S, Markwardt C, Clermont G, Gerbig HW, Leiss J, Schwaiger M, Schömig A; Bavarian Reperfusion Alternatives Evaluation (BRAVE) Study Investigators. Kastrati A, et al. Among authors: seyfarth m. JAMA. 2004 Feb 25;291(8):947-54. doi: 10.1001/jama.291.8.947. JAMA. 2004. PMID: 14982910 Clinical Trial.
260 results